Finance

Beta
Lists
MAZE:NASDAQ
Maze Therapeutics Inc
$24.87
+0.04%
(+0.010) 1D
Jun 4, 1:26:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MAZE...
Open
$24.66
High
$25.77
Low
$24.66
Mkt. cap
1.38B
Avg. vol.
557.76K
Volume
220.83K
52-wk high
$53.65
52-wk low
$9.83
EPS
-$2.52
Shares outstanding
55.34M
No. of employees
141
Open
$24.66
High
$25.77
Low
$24.66
Mkt. cap
1.38B
Avg. vol.
557.76K
Volume
220.83K
52-wk high
$53.65
52-wk low
$9.83
EPS
-$2.52
Shares outstanding
55.34M
No. of employees
141
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to MAZE in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for MAZE in the last 3 months.
Highest
Current $24.87
$110.00 (+342.30%)
Average
$63.56 (+155.57%)
Lowest
$46.00 (+84.96%)
News stories
From sources across the web
About Maze Therapeutics Inc
CEO-
Employees141
Founded2017
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Websitemazetx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
20.00M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.11M
25.19M
27.57M
34.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.37M
7.78M
10.49M
12.40M
Operating expense
36.47M
32.96M
38.06M
46.55M
Total operating expenses
36.47M
32.96M
38.06M
46.55M
Operating income
-36.47M
-32.96M
-38.06M
-26.55M
Other non operating income
-
-
-
-
EBT including unusual items
-33.68M
-30.09M
-34.57M
-24.21M
EBT excluding unusual items
-33.68M
-30.09M
-34.57M
-24.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-33.68M
-30.09M
-34.57M
-24.21M
Net profit margin
-
-
-
-121.04%
Earnings per share
-0.77
-0.66
-0.65
-0.45
Interest and investment income
2.80M
2.88M
3.49M
3.21M
Interest expense
-
-
-
-866.00K
Net interest expenses
2.80M
2.88M
3.49M
2.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
-35.82M
-32.39M
-37.56M
-26.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer